Free Trial
LON:ABDX

Abingdon Health (ABDX) Share Price, News & Analysis

Abingdon Health logo
GBX 5.90 +0.05 (+0.77%)
As of 09/29/2025 11:56 AM Eastern

About Abingdon Health Stock (LON:ABDX)

Advanced

Key Stats

Today's Range
5.70
6
50-Day Range
5.37
6.80
52-Week Range
5.10
9.50
Volume
105,123 shs
Average Volume
141,353 shs
Market Capitalization
£11.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abingdon Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABDX Stock News Headlines

Abingdon Health (LON:ABDX) Trading 3.4% Higher - Here's What Happened
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
When Will Abingdon Health Plc (LON:ABDX) Breakeven?
HMG Urgent Care opens in Abingdon
See More Headlines

ABDX Stock Analysis - Frequently Asked Questions

Abingdon Health's stock was trading at GBX 7.92 at the beginning of the year. Since then, ABDX shares have decreased by 25.5% and is now trading at GBX 5.90.

Abingdon Health Plc (LON:ABDX) issued its quarterly earnings results on Monday, March, 24th. The company reported ($0.53) earnings per share for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative trailing twelve-month return on equity of 62.56%.

Shares of ABDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abingdon Health investors own include 4D pharma (DDDD), genedrive (GDR), Novacyt (NCYT), Rolls-Royce Holdings plc (RR.L), Tullow Oil (TLW), Active Energy Group (AEG) and B&M European Value Retail (BME).

Company Calendar

Last Earnings
3/24/2025
Today
9/30/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:ABDX
CIK
N/A
Fax
N/A
Employees
84
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£796.37 thousand
Net Margins
-20.72%
Pretax Margin
N/A
Return on Equity
-62.56%
Return on Assets
-17.93%

Debt

Debt-to-Equity Ratio
46.64
Current Ratio
1.95
Quick Ratio
1.96

Sales & Book Value

Annual Sales
£6.82 million
Price / Sales
1.68
Cash Flow
GBX 2.62 per share
Price / Cash Flow
2.25
Book Value
GBX 0.73 per share
Price / Book
8.11

Miscellaneous

Outstanding Shares
193,631,000
Free Float
N/A
Market Cap
£11.42 million
Optionable
Not Optionable
Beta
0.13
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:ABDX) was last updated on 9/30/2025 by MarketBeat.com Staff
From Our Partners